Clinical Trial Update: Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating sitagliptin for non-alcoholic steatohepatitis in patients with type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Type 2 Diabetes, Nonalcoholic Steatohepatitis | NA | Status: TERMINATED